Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2000
08/03/2000WO2000044740A2 Heteroaryl acetylenic sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044739A1 Reverse hydroxamate inhibitors of matrix metalloproteinases
08/03/2000WO2000044737A1 Aminoalkylbenzofurans as serotonin (5-ht(2c)) agonists
08/03/2000WO2000044730A1 2,3,4,5-tetrahydro-1h-[1,4]benzodiazepine-3-hydroxamic acid as matrix metalloproteinase inhibitors
08/03/2000WO2000044728A1 Substituted bicyclic derivatives useful as anticancer agents
08/03/2000WO2000044726A1 2h-phthalazin-1-one derivatives and drugs comprising these derivatives as the active ingredient
08/03/2000WO2000044725A1 Fused dihydropyridines and use of fused dihydropyridines in the preparation of agents for the treatment of epilepsy
08/03/2000WO2000044723A1 Alkynyl containing hydroxamic acid derivatives, their preparation and their use as matrix metalloproteinase (mmp) inhibitors/tnf-alpha converting enzyme (tace) inhibitors
08/03/2000WO2000044722A1 Chondrongenesis promotors and indolin-2-one derivatives
08/03/2000WO2000044721A1 3,7-disubstituted indole derivatives and medicinal compositions containing the same
08/03/2000WO2000044718A1 Carotenoid degradation products having an anti-tumoral effect
08/03/2000WO2000044716A1 Acetylenic sulfonamide thiol tace inhibitors
08/03/2000WO2000044715A1 Novel aralkylguanidine compounds
08/03/2000WO2000044714A1 S-nitrosothiols as agents for the treatment of circulatory dysfunctions
08/03/2000WO2000044713A1 Alkynyl containing hydroxamic acid compounds as tace inhibitors
08/03/2000WO2000044711A1 ACETYLENIC $G(b)-SULFONAMIDO AND PHOSPHINIC ACID AMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044710A2 Acetylenic aryl sulfonamide and phosphinic acid amide hydroxamic acid tace inhibitors
08/03/2000WO2000044709A2 ACETYLENIC α-AMINO ACID-BASED SULFONAMIDE HYDROXAMIC ACID TACE INHIBITORS
08/03/2000WO2000044443A2 Intra-pericardial delivery of anti-microtubule agents
08/03/2000WO2000044432A1 Compositions, kits, apparatus, and methods for inhibiting cerebral neurovascular disorders and muscular headaches
08/03/2000WO2000044409A1 Formulations comprising antisense nucleotides to connexins
08/03/2000WO2000044408A2 Method of treating demyelinating inflammatory disease using ccr1 antagonists
08/03/2000WO2000044399A2 Treatment of erectile dysfunctions with a c-type natriuretic polypeptide (cnp) as monotherapy or in combination with phosphodiesterase inhibitors
08/03/2000WO2000044398A2 Methods for increasing circulating platelets for collection and cryopreservation using thrombopoietin compositions
08/03/2000WO2000044392A2 Identification of specific differentially expressed mycobacterial antigens
08/03/2000WO2000044388A1 Modulation of immune response by ribavirin
08/03/2000WO2000044387A1 Organoboron compounds exhibiting anticoccidial activities
08/03/2000WO2000044386A1 Method for treatment of headache
08/03/2000WO2000044385A1 Pharmaceutical combination of progesterone and folic acid
08/03/2000WO2000044384A1 USE OF PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE DERIVATIVES FOR PREPARING MEDICINES FOR TREATING DISEASES RELATED TO THE DYSFUNCTION OF PERIPHERAL BENZODIAZEPIN RECEPTORS
08/03/2000WO2000044383A1 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives
08/03/2000WO2000044382A1 Composition and method for treating diabetes
08/03/2000WO2000044381A1 Treatment of lymphomas, leukemias, and leiomyomas
08/03/2000WO2000044379A2 Methods for restoring and/or enhancing accommodation in pseudo phakia
08/03/2000WO2000044378A1 Use of angiotensin ii receptor antagonists for treating acute myocardial infarction
08/03/2000WO2000044377A1 Mono-acyloxy aralkyl neuromuscular relaxants
08/03/2000WO2000044376A1 Antidepressant heterocyclic compounds
08/03/2000WO2000044375A1 Antioxidant compositions and methods for companion animals
08/03/2000WO2000044374A1 Use of anticonvulsant derivatives for treating bulimia nervosa
08/03/2000WO2000044373A1 Antibacterial hydroxamic acid derivatives
08/03/2000WO2000044372A1 A method for treating patients with acne by administering a cyclic gmp pde inhibitor
08/03/2000WO2000044371A1 2-adamantanemethanamine compounds for treating abnormalities in glutamatergic transmission
08/03/2000WO2000044370A1 Drugs, foods and oral compositions containing stilbene-type compounds
08/03/2000WO2000044369A1 Parenteral solution of propofol (2,6-diisoprophylphenol) and 2.5- di- 0- methyl- 1.4;3.6- dianhydro- d- glucitol as a solvent
08/03/2000WO2000044368A1 Dermatological compounds
08/03/2000WO2000044367A2 A pharmaceutical composition of complex carbohydrates and essential oils and methods of using the same
08/03/2000WO2000044365A1 Methods for preventing graft rejection and ischemia-reperfusion injury
08/03/2000WO2000044364A2 P53 inhibitors and their use for the treatment of cancer, hyperthermia, hypoxia, a burn, trauma to the central nervous system, a seizure, acute inflammation, tissue ageing, preservation of organs for transplant and preparation of a host for bone marrow transplant
08/03/2000WO2000044363A2 Desmethylsildenafil compositions and uses for treating angina and erectile dysfunctions
08/03/2000WO2000044362A2 The use of 4-h-1-benzopyran-4-one derivatives as inhibitors of smooth muscle cell proliferation
08/03/2000WO2000044361A2 Highly purified ethyl epa and other epa derivatives for psychiatric and neurological disorders
08/03/2000WO2000044360A2 Drugs for treatment of psychiatric and brain disorders
08/03/2000WO2000044359A2 Utilisation of thiadizole derivatives for the prophylactic and therapeutic treatment of infections
08/03/2000WO2000044358A2 Use of phosphororganic compounds for the prophylactic and therapeutical treatment of infections
08/03/2000WO2000044357A2 Agent for preventing in-stent restenoses and post-operative inflammations
08/03/2000WO2000044354A1 Lyophilisates with improved reconstitutibility
08/03/2000WO2000044353A1 Pharmaceutical compositions
08/03/2000WO2000044352A1 Method of preparing particles for agglomeration
08/03/2000WO2000044346A1 Lowering skin temperature
08/03/2000WO2000044342A1 Galenic formulation containing biotin
08/03/2000WO2000044334A2 Novel injectable muscle relaxant formulations
08/03/2000WO2000044333A2 Novel injectable antimalarial compositions of artemisinin
08/03/2000WO2000044230A1 A method of controlling fungal pathogens, and agents useful for same
08/03/2000WO2000044225A1 TREATING CANCERS ASSOCIATED WITH OVEREXPRESSION OF HER-2/neu
08/03/2000WO2000044216A2 Gambogic acid, analogs and derivatives as activators of caspases and inducers of apoptosis
08/03/2000WO2000037062A3 Phospholipid complexes of proanthocyanidin a2 as antiatherosclerotic agents
08/03/2000WO2000032175A3 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY
08/03/2000WO2000028947A3 Use of a substance binding with the peripheral benzodiazepin receptor for treating skin stress
08/03/2000WO2000028061A3 Adeno-associated virus serotype 1 nucleic acid sequences, vectors and host cells containing same
08/03/2000WO2000027874A3 Nucleic acids encoding transferrin receptor-like proteins and products related thereto
08/03/2000WO2000027850A3 Crf receptor antagonists and methods relating thereto
08/03/2000WO2000026254A3 Antibodies binding to the aav capsid, antibodies modifying cytotropism, method for targeted gene transfer
08/03/2000WO2000025765A3 Aqueous drug formulation for oral application
08/03/2000WO2000024412A3 Use of vegf-c or vegf-d gene or protein to prevent restenosis
08/03/2000WO2000024387A3 A method for preventing, reducing, and treating radiation cystitis using hyaluronic acid
08/03/2000WO2000023407A3 Ureido-thiobutyric acid derivatives as ppar-agonists
08/03/2000WO2000023065A3 Storable active substance concentrate with formoterol
08/03/2000WO2000021926A3 6-SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS
08/03/2000WO2000021520A3 Opioid analgesic
08/03/2000WO2000020421A3 TRICYCLIC Δ3-PIPERIDINES AS α2-ANTAGONISTS
08/03/2000WO2000017346A3 Hairpin hybridizer molecules for modulation of gene expression
08/03/2000WO2000016754A3 Antiviral combinations comprising lamivudine and lobucavir
08/03/2000WO2000015179A3 Cosmetic composition
08/03/2000WO2000012110A3 Use of anti(w)pressor agents for vascular remodeling in genital dysfunction
08/03/2000WO2000012044A3 Method for the preparation of citalopram
08/03/2000WO2000010533A9 Compositions and methods for treating intracellular infections
08/03/2000WO2000009691A9 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells
08/03/2000WO2000009102A9 Carboxylic acids and isosteres of n-heterocyclic compounds for vision and memory disorders
08/03/2000WO2000008051A3 Immunological herpes simplex virus antigens and methods for use thereof
08/03/2000WO2000008006A3 Piperidine and piperazine derivatives, process for their preparation and pharmaceutical compounds containing them
08/03/2000WO2000007587A9 Composition and method for treating peyronie's disease and other sub-dermal plaque manifestation disorders
08/03/2000WO2000006582A9 Trimeric and polymeric alkaloids
08/03/2000WO2000006146A9 Substituted anilide compounds and methods
08/03/2000WO1999063975A3 A method for stimulating the immune system
08/03/2000WO1999026942A8 5-(2-imidazolinylamino)-benzimidazole derivatives, their preparation and their use as .alpha.-adrenoceptor agonists with improved metabolic stability
08/03/2000DE19943321A1 Anellierte Dihydropyridine und Verwendung von anellierten Dihydropyridinen für die Herstellung von Mitteln für die Behandlung von Epilepsie Fused-dihydropyridines and use of fused dihydropyridines for the production of agents for the treatment of epilepsy
08/03/2000DE19903894A1 Synergistic muscle relaxant combination of vecuronium and rocuronium, is effective at low doses and gives rapid onset of action and short recovery time
08/03/2000DE19903666A1 Arzneimittel mit einem Gehalt an 3-Isoxazolidinonen und Hydroxylaminsäuren als Wirkstoff und ihre Verwendung Drug with a content of 3-Isoxazolidinonen Hydroxylaminsäuren and as active ingredient and their use
08/03/2000DE19903385A1 Mittel zur Prävention von In-Stent Restenosen und postoperativen Entzündungen Agents for the prevention of in-stent restenosis and postoperative inflammation
08/03/2000DE19903275A1 Lyophilisate mit verbesserter Rekonstituierbarkeit Lyophilisates with improved reconstitutability
1 ... 6268 6269 6270 6271 6272 6273 6274 6275 6276 6277 6278 6279 6280 6281 6282 6283 6284 6285 6286 6287 6288 ... 7860